📰 Adxs News
Page 2 - Adxs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adxs. Real-time updates on events, politics, business and more.
December 30, 2023
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Get Our Latest Stock Analysis on […]
December 29, 2023
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Analysis on Ayala […]
December 14, 2023
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Research Report on ADXS […]
December 13, 2023
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reissued a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Analysis on Ayala […]
November 28, 2023
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reissued a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Research […]
November 3, 2023
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Shares of ADXS opened at $0.88 on Tuesday. The firm has a market cap of $1.60 million, a P/E ratio of […]
October 27, 2023
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Trading Up 26.6 % Shares of ADXS stock opened at $0.95 on Monday. Ayala Pharmaceuticals has a twelve month low of $0.65 and […]
October 26, 2023
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Stock Performance NASDAQ ADXS opened at $0.75 on Monday. Ayala Pharmaceuticals has a 52-week low of $0.65 and a 52-week high of $3.75. The company […]
October 11, 2023
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Saturday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Shares of NASDAQ ADXS opened at $1.00 on Friday. Ayala Pharmaceuticals has a one year low of $0.65 and a one year […]
October 2, 2023
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Stock Up 17.5 % Shares of NASDAQ ADXS opened at $0.94 on Friday. Ayala Pharmaceuticals has a 52 week low of $0.65 and […]